Search Results
Jun 08, 2026, 09:01 ET Arc XP and Tickaroo Partner to Bring Live Blogging Workflows to Media Organizations
Arc XPArc XP is the content platform and operating system built to power growth for ambitious media companies. Developed by The Washington Post, Arc XP is used by leading media organizations worldwide, including The Irish Times, Libération, L'Express, RND, Graham Media Group, and Sky News. Arc
More news about: Arc XP
Jun 08, 2026, 09:00 ET GoMacro® Launches MacroSquares™: A New Bar Format with Layered Textures and a Half-Dipped Finish
satisfying, layered experience that feels intentional and grounding. Whether enjoyed between meetings, as a last-minute carpool line snack, or a grounding post-lunch treat, MacroSquares transform an in-between moment into a mini respite from the rush."We have a close relationship with our consumers,
More news about: GoMacro
Jun 08, 2026, 09:00 ET BetaNXT CEO Robert Santella Named FinTech Business Leader of the Year at the 2026 FTF News Technology Innovation Awards
professionals, financial technology vendors, service providers, industry bodies, and regulators that have made significant and noteworthy achievements in post-trade processing operational excellence over the previous calendar year. BetaNXT and other winners will be honored at a gala to be held in New York
More news about: BetaNXT
Jun 08, 2026, 09:00 ET Tata Technologies Receives Frost & Sullivan's 2026 Asia-Pacific Company of the Year Recognition for Excellence in End-to-End Autonomous Vehicle Solutions
distinguishes itself through a full-vehicle, lifecycle-oriented engineering model that spans concept, system architecture, validation, industrialization, and post-launch support. This system-level, platform-driven approach enables OEMs to translate autonomous and ADAS innovations into production-ready, compliant,
More news about: Frost & Sullivan
Jun 08, 2026, 09:00 ET Tata Technologies Receives Frost & Sullivan's 2026 Asia-Pacific Company of the Year Recognition for Excellence in End-to-End Autonomous Vehicle Solutions
distinguishes itself through a full-vehicle, lifecycle-oriented engineering model that spans concept, system architecture, validation, industrialization, and post-launch support. This system-level, platform-driven approach enables OEMs to translate autonomous and ADAS innovations into production-ready, compliant,
More news about: Frost & Sullivan
Jun 08, 2026, 08:30 ET Kye Pharmaceuticals Announces the Availability of Dyanavel® XR Tablets Across Canada for the Treatment of ADHD
the treatment of ADHD in children 6 to 12 years of age as well as in adults 18 years of age and over. The onset of action is significant at 60 minutes post dose with a duration of therapy of 13 hours.1 Dyanavel® XR tablets are available now. The oral suspension formulation will be delayed, pending
More news about: Kye Pharmaceuticals Inc.
Jun 08, 2026, 08:30 ET Neurocrine Biosciences Presents New Data Highlighting Functional and Socio-emotional Improvements with INGREZZA® (valbenazine) Capsules in Individuals with Tardive Dyskinesia and Intellectual and Developmental Disabilities
occur or be submitted in a timely manner; risks that the FDA or other regulatory authorities may make adverse decisions regarding INGREZZA; risks that post-approval INGREZZA commitments or requirements may be delayed; risks that INGREZZA may be precluded from commercialization by the proprietary or regulatory
More news about: Neurocrine Biosciences, Inc.
Jun 08, 2026, 08:05 ET THERABODY LAUNCHES CRYOTHERM™ PALM, ITS FIRST THERMOREGULATION PERFORMANCE DEVICE, BRINGING SCIENCE-BACKED PALM COOLING TO MANAGE HEAT ON SPORT'S BIGGEST STAGE
cold therapy, localized heat therapy, and contrast therapy, giving athletes and performance staff a single device for both in-session performance and post-session recovery.Additional CryoTherm Palm features:Three scientifically calibrated cold temperature levels (46.4°F
More news about: Therabody
Jun 08, 2026, 08:05 ET THERABODY LAUNCHES CRYOTHERM™ PALM, ITS FIRST THERMOREGULATION PERFORMANCE DEVICE, BRINGING SCIENCE-BACKED PALM COOLING TO MANAGE HEAT ON SPORT'S BIGGEST STAGE
cold therapy, localized heat therapy, and contrast therapy, giving athletes and performance staff a single device for both in-session performance and post-session recovery.Additional CryoTherm Palm features:Three scientifically calibrated cold temperature levels (46.4°F
More news about: Therabody
Jun 08, 2026, 08:05 ET SEI and Accenture Release AI Adoption Maturity Model to Help Organizations Scale AI with Predictable Outcomes
Rethinking and Maturing AI Adoption," June 9 at 1:30 p.m. EDT.Learn more about the model in the SEI Blog post
More news about: Carnegie Mellon University Software Engineering Institute
Jun 08, 2026, 08:00 ET Argo Biopharma to Present Positive Phase II Updated Results of siRNA Therapeutic BW-20805 for HAE at the EAACI 2026 Congress
with post-dose data beyond Day 29). Time-normalized HAE attack rate was reduced by 99% in 600 mg Q24W with 83% (5/6) attack-free, 93% in 300 mg Q24W with 60% (3/5) attack-free, and 95% in 300 mg Q12W with 60% (3/5) attack-freeAs of cut-off, 17 participants had post-dose
More news about: Argo Biopharmaceutical Co., Ltd
Jun 08, 2026, 08:00 ET AbbVie Presents New Data Across Its Blood Cancer Portfolio at EHA 2026
NCT03987958), examining the effect of antimicrobial prophylaxis, post-remission administration of G-CSF and treatment initiation setting on safety and effectiveness outcomes with venetoclax plus hypomethylating agents
More news about: AbbVie
Jun 08, 2026, 08:00 ET AbbVie Presents New Data Across Its Blood Cancer Portfolio at EHA 2026
NCT03987958), examining the effect of antimicrobial prophylaxis, post-remission administration of G-CSF and treatment initiation setting on safety and effectiveness outcomes with venetoclax plus hypomethylating agents
More news about: AbbVie
Jun 08, 2026, 07:30 ET Soligenix Applying for Vaccine Development Funding for Bundibugyo Ebola Vaccine
Orphan Drug Designation by the United States Food and Drug Administration (FDA) for the prevention and post-exposure prophylaxis against Orthoebolavirus sudanense and Orthomarburgvirus marburgense infection. In addition to providing
More news about: SOLIGENIX, INC.
Jun 08, 2026, 07:00 ET Sempra Infrastructure Names Bhavesh "Bob" Patel Incoming Chief Executive Officer
completed, (v) obtaining regulatory and other approvals and (vi) third parties honoring their contracts and commitments, including with respect to closing or post-closing payments; changes to our capital expenditure plans and their potential impact on growth; changes, due to evolving economic, political and other
More news about: Sempra Infrastructure
Jun 08, 2026, 06:30 ET Broadridge's Distributed Ledger Repo Achieves 220% Year Over Year Growth; Processes $7.2 Trillion in May
Tokenization SolutionsBroadridge enables on-chain proxy voting and governance, digital asset infrastructure including post trade, wallets and custody, and the scaling of digital asset capabilities across multiple asset classes. Through these innovations, Broadridge
More news about: Broadridge Financial Solutions, Inc.
Jun 08, 2026, 06:30 ET QUANTUM SPACE, A LEADING SPACE DEFENSE AND ORBITAL MOBILITY COMPANY, TO GO PUBLIC VIA MERGER WITH INFLECTION POINT ACQUISITION CORP. VI
Transaction includes an initial $300M PIPE investment anchored by Inflection Point; pre-money equity value of approximately $600M and a post-transaction equity value of approximately $1.2B Parties to host a virtual webcast today at 8:30 a.m. ET:
More news about: Quantum Space
Jun 08, 2026, 06:00 ET PAM Health and Marshall Health Network announce plans to open 42-bed medical rehabilitation hospital in South Point, Ohio
injuries, strokes and other neurological disorders, cardiac conditions, amputations, orthopedic and post-surgical needs.PAM Health, PAM Health, based in Enola, Pennsylvania, provides post-acute healthcare services through more than 100 long-term acute care hospitals, medical rehabilitation
More news about: PAM Health
Jun 08, 2026, 06:00 ET HONEYWELL REAFFIRMS 2026 OUTLOOK AHEAD OF HONEYWELL AEROSPACE SPIN-OFF; INITIATES 2026 OUTLOOK FOR HONEYWELL TECHNOLOGIES
guidance ahead of the planned Honeywell Aerospace spin-off on June 29, 2026. The company also provided a preliminary 2026 outlook for the remaining company post spin, which will conduct business under the name Honeywell Technologies. The company will discuss its latest outlook for 2026 during an investor conference
More news about: Honeywell
Jun 08, 2026, 05:00 ET Foresee's Oral ALDH2 Activator, Mirivadelgat to Enter Clinical Testing in Parkinson's Disease in the SLEIPNIR Phase 2a Platform Trial
mirivadelgat versus 30 participants receiving placebo across the platform. Participants will receive study treatment for 12 weeks, followed by a two-week post-treatment safety follow-up. The primary assessment will take place at the end of the 12-week treatment period, with the week-14 visit used to evaluate
More news about: Foresee Pharmaceuticals Co., Ltd.
Jun 08, 2026, 04:30 ET 2026 ADA | Innovent Presents Multiple Clinical and Preclinical Results of Next-Generation Obesity & Metabolic Pipeline
increased in an approximately dose-proportional manner across 0.3–6 mg dose range; peak plasma concentration (Tmax) occurred 5–12 hours post-dose. Its terminal elimination half-life is (T1/2) approximately 2 days, which supports a once-daily dosing regimen. Pharmacokinetics (PK) parameters
More news about: Innovent Biologics
Jun 08, 2026, 03:04 ET DL Holdings' Fourth "Victoria Harbour Night Talk": The AI Wave: Global Investment & Hong Kong Opportunities
technology is still in its early stages, but is already having a significant disruptive impact on entry-level roles in animation design, visual effects, and post-production editing. In the long run, creativity and aesthetic sensibility will become the more critical core competencies.The second panel, themed
More news about: DL Holdings
Jun 08, 2026, 03:00 ET Deutscher Image Award 2026 geht an Oliver Zipse und das Kommunikationsteam der BMW AG
Börse AG2018: Kasper Rorsted und Jan Runau, Adidas AG2017: Dr. Frank Appel und Prof. Dr. Christof Ehrhart, Deutsche Post DHL Group2016: Dr. Karl-Ludwig Kley und Dr. Walter Huber, Merck KGaA2015: Dr. Dieter Zetsche und Jörg Howe, Daimler
More news about: F.A.Z. Institut
Jun 07, 2026, 20:08 ET OriCell's GPC3 CAR-T Receives NMPA Clearance for Confirmatory Phase II Trial in Late-Line Advanced Hepatocellular Carcinoma
cohort; 100% in the highest dose cohort (DL4)Speed of response: 89% of responders had already achieved objective response by their first post-infusion assessment, with marked tumour shrinkageOverall survival (OS): Median OS of 21.4 months in the overall population; 12-month survival
More news about: Oricell Therapeutics Holdings Limited
Jun 07, 2026, 11:00 ET Lilly's Foundayo (orforglipron), the only oral GLP-1 taken without food or water restrictions, was associated with significant weight loss in women at every stage of menopause
stages. In ATTAIN‑1, women who were pre‑, peri‑ and post‑menopausal lost up to 28.0 lbs (12.8%), 30.4 lbs (14.4%) and 28.2 lbs (14.1%) respectively on the highest dose of Foundayo. In ATTAIN‑2, women with type 2 diabetes who were pre‑, peri‑ and post‑menopausal lost up to 23.4 lbs (11.3%), 18.5 lbs (8.9%)
More news about: Eli Lilly and Company